Fig. 1 · Structure
Documents & Downloads
Ozuriftamab vedotin
Cat. No.
A41739
CAS
2460400-11-5
ROR2 ADC
Ozuriftamab vedotin is an antibody-drug conjugate (ADC) targeting the receptor tyrosine kinase orphan receptor 2 (ROR2). This compound combines a humanized monoclonal antibody, Ozuriftamab, with the cytotoxic agent VcMMAE, enabling selective delivery to ROR2-expressing tumor cells. Ozuriftamab vedotin exhibits potent antitumor activity and is utilized in research focused on cancer therapeutics and targeted therapies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 2460400-11-5 |
| Applications | ROR2 ADC |
| Synonyms | BA3021; Anti-ROR2 ADC; CAB-ROR2-ADC |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.